Antonio Citro

1.9k total citations
41 papers, 950 citations indexed

About

Antonio Citro is a scholar working on Surgery, Genetics and Oncology. According to data from OpenAlex, Antonio Citro has authored 41 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Surgery, 13 papers in Genetics and 11 papers in Oncology. Recurrent topics in Antonio Citro's work include Pancreatic function and diabetes (25 papers), Diabetes and associated disorders (11 papers) and Tissue Engineering and Regenerative Medicine (10 papers). Antonio Citro is often cited by papers focused on Pancreatic function and diabetes (25 papers), Diabetes and associated disorders (11 papers) and Tissue Engineering and Regenerative Medicine (10 papers). Antonio Citro collaborates with scholars based in Italy, United States and Germany. Antonio Citro's co-authors include Lorenzo Piemonti, Elisa Cantarelli, Alessia Mercalli, Raffaella Melzi, Erica Dugnani, Silvia Pellegrini, Valeria Sordi, Rita Nano, Antonio Secchi and Paola Maffi and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Biomaterials.

In The Last Decade

Antonio Citro

40 papers receiving 941 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonio Citro Italy 16 499 281 262 238 185 41 950
Mijke Buitinga Netherlands 15 265 0.5× 131 0.5× 95 0.4× 149 0.6× 155 0.8× 37 647
Elisa Cantarelli Italy 15 628 1.3× 377 1.3× 239 0.9× 187 0.8× 294 1.6× 19 946
Kristie Aamodt United States 9 406 0.8× 233 0.8× 63 0.2× 218 0.9× 174 0.9× 13 625
Gillian I. Bell Canada 17 265 0.5× 72 0.3× 91 0.3× 363 1.5× 84 0.5× 34 730
Hirotake Komatsu United States 14 472 0.9× 145 0.5× 45 0.2× 154 0.6× 193 1.0× 48 735
Erica Dugnani Italy 15 299 0.6× 121 0.4× 169 0.6× 367 1.5× 140 0.8× 20 834
Yvonne Nitschke Germany 20 133 0.3× 706 2.5× 198 0.8× 462 1.9× 149 0.8× 40 1.5k
Masayuki Shimoda Japan 25 1.3k 2.5× 611 2.2× 66 0.3× 419 1.8× 615 3.3× 104 1.7k
Nico De Leu Belgium 16 1.1k 2.2× 665 2.4× 60 0.2× 450 1.9× 546 3.0× 29 1.3k
Carmen Huesa United Kingdom 17 93 0.2× 151 0.5× 57 0.2× 322 1.4× 252 1.4× 42 896

Countries citing papers authored by Antonio Citro

Since Specialization
Citations

This map shows the geographic impact of Antonio Citro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Citro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Citro more than expected).

Fields of papers citing papers by Antonio Citro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Citro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Citro. The network helps show where Antonio Citro may publish in the future.

Co-authorship network of co-authors of Antonio Citro

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Citro. A scholar is included among the top collaborators of Antonio Citro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Citro. Antonio Citro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pignatelli, Cataldo, et al.. (2025). Bioprinting and synthetic biology approaches to engineer functional endocrine pancreatic constructs. Trends in biotechnology. 43(9). 2133–2149. 3 indexed citations
2.
3.
Pignatelli, Cataldo, Silvia Pellegrini, Ilaria Marzinotto, et al.. (2025). Bioengineering of a human iPSC-derived vascularized endocrine pancreas for type 1 diabetes. Cell Reports Medicine. 6(2). 101938–101938. 4 indexed citations
4.
Pocaterra, Arianna, Antonio Citro, Chiara Gnasso, et al.. (2024). A preclinical mouse model of hepatic metastasis to instruct effective treatment modalities. Methods in cell biology. 190. 133–150. 1 indexed citations
5.
Ferrara, Benedetta, Antonio Citro, Marco Schiavo Lena, et al.. (2024). ASO Author Reflections: Bridging the Gap in PDAC Research: The Intraportal Model as a Platform for Studying Preclinical Liver Metastasis. Annals of Surgical Oncology. 31(10). 7066–7067. 1 indexed citations
6.
Ferrara, Benedetta, Antonio Citro, Marco Schiavo Lena, et al.. (2024). Establishment of a Transplantation Model of PDAC-Derived Liver Metastases. Annals of Surgical Oncology. 31(9). 6138–6146. 1 indexed citations
7.
Piemonti, Lorenzo, et al.. (2024). Pig Xenotransplantation in Beta Cell Replacement: Addressing Challenges and Harnessing Potential for Type 1 Diabetes Therapy. Transplant International. 37. 13122–13122. 4 indexed citations
8.
Citro, Antonio, Cataldo Pignatelli, Matteo Monieri, et al.. (2023). Directed self-assembly of a xenogeneic vascularized endocrine pancreas for type 1 diabetes. Nature Communications. 14(1). 878–878. 24 indexed citations
9.
Caldara, Rossana, Paolo Monti, Valeria Sordi, et al.. (2023). Allo Beta Cell transplantation: specific features, unanswered questions, and immunological challenge. Frontiers in Immunology. 14. 1323439–1323439. 9 indexed citations
10.
Monieri, Matteo, Angelina Sacchi, Alessandro Gori, et al.. (2022). A stapled chromogranin A-derived peptide homes in on tumors that express αvβ6 or αvβ8 integrins. International Journal of Biological Sciences. 19(1). 156–166. 6 indexed citations
12.
Reni, Michele, Valentina Andreasi, Anna Maria Gasparri, et al.. (2020). Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology. 10. 613582–613582. 1 indexed citations
13.
Citro, Antonio, et al.. (2019). CCL2/MCP-1 and CXCL12/SDF-1 blockade by L-aptamers improve pancreatic islet engraftment and survival in mouse. American Journal of Transplantation. 19(11). 3131–3138. 15 indexed citations
14.
Citro, Antonio, Philipp T. Moser, Taufiek Konrad Rajab, et al.. (2019). Biofabrication of a vascularized islet organ for type 1 diabetes. Biomaterials. 199. 40–51. 61 indexed citations
15.
Peloso, Andrea, Antonio Citro, Lorenzo Cobianchi, et al.. (2018). Regenerative Medicine and Diabetes: Targeting the Extracellular Matrix Beyond the Stem Cell Approach and Encapsulation Technology. Frontiers in Endocrinology. 9. 445–445. 17 indexed citations
16.
Citro, Antonio & Harald C. Ott. (2018). Can We Re-Engineer the Endocrine Pancreas?. Current Diabetes Reports. 18(11). 122–122. 7 indexed citations
17.
Cantarelli, Elisa, Antonio Citro, Silvia Pellegrini, et al.. (2016). Transplant Site Influences the Immune Response After Islet Transplantation. Transplantation. 101(5). 1046–1055. 25 indexed citations
18.
Peloso, Andrea, Antonio Citro, Manuela Currao, et al.. (2015). Creation and implantation of acellular rat renal ECM-based scaffolds. Organogenesis. 11(2). 58–74. 36 indexed citations
19.
Citro, Antonio, Elisa Cantarelli, & Lorenzo Piemonti. (2015). The CXCR1/2 Pathway: Involvement in Diabetes Pathophysiology and Potential Target for T1D Interventions. Current Diabetes Reports. 15(10). 68–68. 27 indexed citations
20.
Marzorati, Simona, Raffaella Melzi, Antonio Citro, et al.. (2014). Engraftment Versus Immunosuppression. Transplantation. 97(10). 1019–1026. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026